Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study

BackgroundAlthough plasma fibrinogen levels are related to cardiovascular risk, data regarding the role of fibrinogen genetic variation in myocardial infarction (MI) or coronary artery disease (CAD) etiology remain inconsistent. The purpose of the present study was to investigate the effect of fibrinogen A (FGA), fibrinogen B (FGB) and fibrinogen G (FGG) gene SNPs and haplotypes on susceptibility to CAD in a homogeneous Greek population.MethodsWe genotyped for rs2070022, rs2070016, rs2070006 in FGA gene, the rs7673587, rs1800789, rs1800790, rs1800788, rs1800787, rs4681 and rs4220 in FGB gene and for the rs1118823, rs1800792 and rs2066865 SNPs in FGG gene applying an arrayed primer extension-based genotyping method (APEX-2) in a sample of CAD patients (n = 305) and controls (n = 305). Logistic regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs), before and after adjustment for potential confounders.ResultsNone of the FGA and FGG SNPs and FGA, FGB, FGG and FGA-FGG haplotypes was associated with disease occurrence after adjustment. Nevertheless, rs1800787 and rs1800789 SNPs in FGB gene seem to decrease the risk of CAD, even after adjustment for potential confounders (OR = 0.42, 95%CI: 0.19-0.90, p = 0.026 and OR = 0.44, 95%CI:0.21-0.94, p = 0.039, respectively).ConclusionsFGA and FGG SNPs as well as FGA, FGB, FGG and FGA-FGG haplotypes do not seem to be important contributors to CAD occurrence in our sample. On the contrary, FGB rs1800787 and rs1800789 SNPs seem to confer protection to disease onset lowering the risk by about 50% in homozygotes for the minor alleles.

[1]  A. Hamsten,et al.  Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[2]  E. Davie,et al.  gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. , 1984, Biochemistry.

[3]  W. Reinhart.  Fibrinogen - marker or mediator of vascular disease? , 2003, Vascular medicine.

[4]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[5]  A. Hamsten,et al.  Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction , 2005, Thrombosis and Haemostasis.

[6]  J. Powell,et al.  Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Houwing-Duistermaat,et al.  Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. , 2005, Blood.

[8]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[9]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[10]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[11]  G. Crabtree,et al.  Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[13]  S. Humphries,et al.  A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. , 1997, Journal of Clinical Investigation.

[14]  A. Peters,et al.  Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. , 2008, Journal of the American College of Cardiology.

[15]  R. Mägi,et al.  Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays , 2008, Nucleic acids research.

[16]  A. Hofman,et al.  Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: The Rotterdam Study , 2007, Thrombosis and Haemostasis.

[17]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[18]  Jean-Louis Golmard,et al.  Specific haplotypes of the P-selectin gene are associated with myocardial infarction. , 2002, Human molecular genetics.

[19]  C. Carlson,et al.  Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults , 2008, Thrombosis and Haemostasis.

[20]  A. Craig,et al.  Molecular Identification of a Novel Fibrinogen Binding Site on the First Domain of ICAM-1 Regulating Leukocyte-Endothelium Bridging* , 1997, The Journal of Biological Chemistry.

[21]  R. Peters,et al.  Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial Infarction: A Systematic Review , 2001, Circulation.

[22]  A. van de Stolpe,et al.  Fibrinogen Binding to ICAM-1 on EA.hy 926 Endothelial Cells Is Dependent on an Intact Cytoskeleton , 1996, Thrombosis and Haemostasis.

[23]  L. Rallidis,et al.  G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece. , 2010, Thrombosis research.

[24]  W. Koenig.  Fibrin(ogen) in cardiovascular disease: an update , 2003, Thrombosis and Haemostasis.

[25]  G. Di Minno,et al.  Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[26]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[27]  A. Hamsten,et al.  The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL‐6 concentration , 2007, Journal of internal medicine.

[28]  Per Eriksson,et al.  Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction , 2006, Thrombosis and Haemostasis.

[29]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[30]  A. Kastrati,et al.  Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.